Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatment.
Hirt D, Bardin C, Diagbouga S, Nacro B, Hien H, Zoure E, Rouet F, Ouiminga A, Urien S, Foulongne V, Van De Perre P, Tréluyer JM, Msellati P. Hirt D, et al. Among authors: zoure e. Antimicrob Agents Chemother. 2009 Oct;53(10):4399-406. doi: 10.1128/AAC.01187-08. Epub 2009 Jul 6. Antimicrob Agents Chemother. 2009. PMID: 19581461 Free PMC article. Clinical Trial.
Is the recommended dose of efavirenz optimal in young West African human immunodeficiency virus-infected children?
Hirt D, Urien S, Olivier M, Peyrière H, Nacro B, Diagbouga S, Zoure E, Rouet F, Hien H, Msellati P, Van De Perre P, Tréluyer JM. Hirt D, et al. Among authors: zoure e. Antimicrob Agents Chemother. 2009 Oct;53(10):4407-13. doi: 10.1128/AAC.01594-08. Epub 2009 Jul 27. Antimicrob Agents Chemother. 2009. PMID: 19635964 Free PMC article. Clinical Trial.
Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?
Bouazza N, Hirt D, Bardin C, Diagbouga S, Nacro B, Hien H, Zoure E, Rouet F, Ouiminga A, Blanche S, Van De Perre P, Tréluyer JM, Msellati P, Urien S. Bouazza N, et al. Among authors: zoure e. Antimicrob Agents Chemother. 2010 Aug;54(8):3280-6. doi: 10.1128/AAC.00306-10. Epub 2010 Jun 1. Antimicrob Agents Chemother. 2010. PMID: 20516271 Free PMC article. Clinical Trial.
24-Month adherence, tolerance and efficacy of once-a-day antiretroviral therapy with didanosine, lamivudine, and efavirenz in African HIV-1 infected children: ANRS 12103/12167.
Hien H, Meda N, Diagbouga S, Zoure E, Yaméogo S, Tamboura H, Somé J, Ouiminga A, Rouet F, Drabo A, Hien A, Nicolas J, Chappuy H, Van de Perre P, Msellati P, Nacro B. Hien H, et al. Among authors: zoure e. Afr Health Sci. 2013 Jun;13(2):287-94. doi: 10.4314/ahs.v13i2.13. Afr Health Sci. 2013. PMID: 24235926 Free PMC article. Clinical Trial.
Pharmacology and immuno-virologic efficacy of once-a-day HAART in African HIV-infected children: ANRS 12103 phase II trial.
Nacro B, Zoure E, Hien H, Tamboura H, Rouet F, Ouiminga A, Drabo A, Yameogo S, Hien A, Peyriere H, Mathieu O, Hirt D, Treluyer JM, Nicolas J, Foulongne V, Segondy M, van de Perre P, Diagbouga S, Msellati P. Nacro B, et al. Among authors: zoure e. Bull World Health Organ. 2011 Jun 1;89(6):451-8. doi: 10.2471/BLT.10.081646. Epub 2011 Apr 6. Bull World Health Organ. 2011. PMID: 21673861 Free PMC article. Clinical Trial.
Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname.
Barro M, Some J, Foulongne V, Diasso Y, Zouré E, Hien H, François R, Michel S, Drabo A, Tamboura H, Ouiminga A, Diagbouga S, Hien A, Yaméogo S, Van De Perre P, Nacro B, Msellati P. Barro M, et al. Among authors: zoure e. J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S44-9. doi: 10.1097/QAI.0b013e31821fd64f. J Acquir Immune Defic Syndr. 2011. PMID: 21857286 Clinical Trial.